← Human Trials & Peer-Reviewed Studies
Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial
Plain-language guide to PMID 39202581 (2024): placebo-controlled randomized controlled trial study of hCG (human chorionic gonadotropin) in 138 individuals.
Key Facts
- PMID
- 39202581
- Journal
- Medicina (Kaunas, Lithuania)
- Year
- 2024
- Study type
- Randomized Controlled Trial
- Authors
- Thabet M et al. (20 authors)
- DOI
- 10.3390/medicina60081300
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of hCG (human chorionic gonadotropin), published as a randomized controlled trial.
Materials and Methods: A randomized controlled trial was carried out on 300 infertile CC-resistant PCOS women.
The number of ovarian follicles > 18 mm, cycle cancellation rate, endometrial thickness, ovulation rate, clinical pregnancy rate, and occurrence of early ovarian hyper-stimulation syndrome were all outcome variables in the primary research.
Who Took Part
The study group was 138 individuals.
PubMed indexes the participants as adults, women only.
All participants were assigned to two groups: the CC-HCG group and the CC-Placebo group.
Subjects in the CC-Placebo group were given CC and a placebo.
How the Study Was Run
In design terms this was a randomized and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got hCG (human chorionic gonadotropin) and who got the comparison, which limits bias.
Some individuals received a placebo instead of hCG (human chorionic gonadotropin), giving a reference point.
What Was Measured
The number of ovarian follicles > 18 mm, cycle cancellation rate, endometrial thickness, ovulation rate, clinical pregnancy rate, and occurrence of early ovarian hyper-stimulation syndrome were all outcome variables in the primary research.
Topics PubMed links to this paper include Clomiphene, Polycystic Ovary Syndrome, Ovulation Induction, Chorionic Gonadotropin, Infertility, Female, Fertility Agents, Female and Pregnancy Rate.
Author keywords: clomiphene citrate, clomiphene resistance, human chorionic gonadotropin and polycystic ovarian syndrome.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of hCG (human chorionic gonadotropin) in 138 individuals.
The publication is from 2024 (Medicina (Kaunas, Lithuania)), a journal based in Switzerland.
More context: the hCG (human chorionic gonadotropin) compound page, all human trials.
Our Notes on the Compound
hCG (human chorionic gonadotropin): An LH analog that drives Leydig-cell testosterone production.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.